2007 Beijing International Pharmaceutical R&D Forum

The 2nd Beijing International Pharma R&D Forum

May 29 - June 1st, GuangXi Hotel, Beijing

Speaker: Dr. Carl Peck, Director, Center for Drug Evaluation and Research (CDER), US FDA
(美国FDA新药审批中心主任) from 1987-1993 and Professor at University of California at San Francisco, USA
Title: Overview of Drug Development and Regulation in the United States

Speaker: Ms. Yali Wu, Director, Department of Policy and Regulation, SFDA, China
(国家食品药品监督管理局政策法规司法规处处长 吴利雅)
Title: Explanation of the newly revised “Guidelines of SFDA Drug Registration”

Speaker: Mr. Guowei Sang, President, National Institute for the Control of Pharmaceutical and Biological Products, China
(中国药品生物制品检定所所长 桑国卫)
Title: International Multi-center Clinical Trials in China: Issues and New Developments

Speaker: Mr. Yanhua Gong, Director, Department of Drug Safety and Inspection, SFDA, China
(国家食品药品监督管理局药品安全监管司研究监督处处长 宫岩华)
Title: Regulations of Clinical Trials in China

Speaker: Mr. Zhang Qingkui, Director, Department of Drug Patents, State Administration of Intellectual Right Protection, China
(国家知识产权局 医药生物发明审查部部长, 张清奎)
Title: New Development and Regulations for Patent Application and IP protection in China

Speaker: (to be determined soon), Center for Drug Evaluation, SFDA, China
Title: The process of drug evaluation and timeline for drug registration

Speaker: Dr. John Piwinski, Group Vice President, Schering-Plough Corp, USA
Title: Meeting the Challenges in drug Discovery

Speaker: Dr. John Ellingbo, Assistant Vice President, Wyeth Corp, USA
Title: The Identification of Secretase Inhibitors for the Treatment of Alzheimer's Disease

Speaker: Dr. Li Chen, Chief Scientific Officer, Roche R&D Center, China
Title: Drug Discovery Research in China: A Fast Developing Landscape

Speaker: Dr. Zaiqi Wang, Director of Clinical Research, Schering-Plough Corp, USA
Title: Early Clinical Development and Clinical pharmacology package needed for FDA approval

Speaker: Dr. Li Zili, Clinical Director, Merck, Inc, China
Title: Drug Discovery: Global Impact, Regulations and China

Speaker: Dr. Chen Zhijian, Clinical Director, GSK, China
Title: Clinical Trials in China: Low Costs and High Efficiency

Speaker: (to be announced soon), Eli lily, China
Title: to be announced soon

Speaker: Mr. He, the Head of Medicine City of China, China
Title: Introduction of the Medicine City of China